Related Experiment Video
Updated: Jan 10, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Advancing the understanding of age-specific phenotypes in childhood-onset takayasu arteritis
Khaled Saad1, Soha A Hussain2, Ahmad Roshdy Ahmad3
1Department of Pediatrics, Assiut University, Assiut, Egypt. Khaled.ali@med.au.edu.eg.
Insights
Childhood-onset Takayasu arteritis (cTAK) presents differently in children of various ages. Tailoring diagnosis and treatment to specific developmental stages is crucial for better outcomes in this rare pediatric vasculitis.
Area of Science:
- Pediatric rheumatology
- Vascular biology
- Developmental biology
Background:
- Childhood-onset Takayasu arteritis (cTAK) is a rare inflammatory condition affecting large arteries.
- Existing knowledge often overlooks the significant impact of developmental stages on cTAK presentation and progression.
Purpose of the Study:
- To characterize age-specific clinical and vascular phenotypes in childhood-onset Takayasu arteritis.
- To propose a framework for age-tailored diagnostic and therapeutic strategies in cTAK.
- To introduce the concept of 'developmental vasculopathy' to explain cTAK manifestations.
Main Methods:
- Retrospective analysis of cTAK patient data stratified by developmental stages (infants, children, adolescents).
- Correlation of clinical symptoms, imaging findings, and treatment responses with age-specific arterial wall maturation.
- Comparative analysis with incomplete Kawasaki disease to refine diagnostic criteria.
Main Results:
- cTAK exhibits distinct clinical and vascular phenotypes that vary significantly across infant, child, and adolescent stages.
- Specific patterns of arterial wall involvement correlate with developmental maturation, termed 'developmental vasculopathy'.
- Diagnostic challenges in differentiating cTAK from incomplete Kawasaki disease are highlighted, particularly in younger age groups.
Conclusions:
- Childhood-onset Takayasu arteritis is not a monolithic disease; age-specific phenotypes necessitate tailored approaches.
- Implementing age-stratified diagnostic and management strategies, guided by 'developmental vasculopathy', can improve patient outcomes.
- Personalized medicine, including precision diagnostics and targeted interventions, represents a new era for managing cTAK in children.
Impact:
Childhood-onset Takayasu arteritis (cTAK) is not a uniform disease but exhibits distinct age-specific clinical and vascular phenotypes across developmental stages, from infants to adolescents. These differences necessitate age-tailored diagnostic approaches and therapeutic strategies to improve outcomes and reduce treatment-related morbidity. The concept of "developmental vasculopathy" links vascular involvement patterns to maturational changes in the arterial wall, addressing critical diagnostic challenges in differentiating incomplete Kawasaki disease from cTAK. The progression toward age-stratified management patterns heralds a new era of personalized medicine in cTAK, with precision diagnostics and tailored interventions to improve outcomes for this serious childhood disease.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis I: Introduction
Rheumatic Heart Disease I: Introduction
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Atherosclerosis III: Management